Internal Medicine, Pulmonary Disease · Yardley, PA
NPI
1336188853
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1000 Floral Vale Blvd, Suite 125
Yardley, PA, 19067
Phone (267) 759-6300
Groups this clinician bills Medicare through
Medicare paid, 2024
$296K
8,510 services
Medicare patients, 2024
374
Average age 74
Drug cost, 2024
$1.5M
3,174 prescriptions
Company payments, 2025
$1,547
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bruce B Dershaw was code 99214 (office e&m - established), 540 times for 312 patients. In total Bruce B Dershaw billed 8,510 services in 15 codes, and Medicare paid $296K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 540 | 312 | $96.03 | $52K |
| 96372 Injection Administration | Office | 131 | 25 | $11.38 | $1,491 |
| 94010 Pulmonary Function Testing | Office | 120 | 112 | $21.21 | $2,545 |
| 94726 Pulmonary Function Testing | Office | 97 | 92 | $43.87 | $4,255 |
| 94729 Pulmonary Function Testing | Office | 92 | 88 | $45.77 | $4,211 |
| 99213 Office E&M - Established | Office | 57 | 54 | $59.22 | $3,376 |
| 99204 Office E&M - New | Office | 13 | 13 | $136.76 | $1,778 |
By year: 2022 $187K for 3,266 services; 2023 $222K for 4,198 services; 2024 $296K for 8,510 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bruce B Dershaw prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 406 prescriptions and refills. In total Bruce B Dershaw wrote 3,174 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 406 | 581 | 81 | $360K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 402 | 537 | 113 | $12K |
| Prednisone Generic | 287 | 351 | 97 | $1,467 |
| Breo Ellipta Fluticasone/Vilanterol | 218 | 310 | 46 | $119K |
| Montelukast Sodium Generic | 183 | 428 | 46 | $2,304 |
| Azithromycin Generic | 147 | 191 | 66 | $1,253 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 143 | 241 | 40 | $26K |
| Spiriva Respimat Tiotropium Bromide | 82 | 113 | 16 | $57K |
| Fluticasone Propionate Generic | 82 | 151 | 19 | $2,059 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 79 | 113 | 13 | $50K |
| Ventolin Hfa Albuterol Sulfate | 68 | 87 | 20 | $5,515 |
| Nucala Mepolizumab | 61 | 61 | Under 11 | $231K |
| Spiriva Handihaler Tiotropium Bromide | 51 | 91 | Under 11 | $45K |
| Clonazepam Generic | 49 | 61 | Under 11 | $242 |
| Alprazolam Generic | 47 | 59 | Under 11 | $186 |
Brand drugs: 1,632 claims; generic drugs: 1,542 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bruce B Dershaw $1,547 ($1,547 in general payments such as food, travel and fees) from 21 companies. The largest payer was GlaxoSmithKline, LLC. with $414.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 29 | $414 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $259 |
| Verona Pharma, Inc. VRNA | 6 | $142 |
| Genzyme Corporation SNY | 3 | $96.29 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $76.26 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $73.27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51.66 |
| Vifor Pharma, Inc. | 2 | $44.85 |
| United Therapeutics Corporation UTHR | 2 | $44.38 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $43.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.